- In September 2023, TePe, a leading oral health brand, announced the launch of a new dental floss made entirely from 100% recycled plastic water bottles. Each 150-metre floss roll repurposes the equivalent of two 0.5-litre plastic bottles, helping to divert waste from landfills. The product features a coating of vegetable wax and avocado oil, is packaged in a fully recyclable outer carton, and is free from PFAS ‘forever chemicals’. This launch follows the company’s earlier release of the TePe Choice toothbrush, which features a reusable wooden handle. The initiative reinforces TePe’s commitment to sustainable oral care and aligns with consumer trends, as research shows 89% of consumers prefer brands that prioritize sustainability
- In December 2023, Young Innovations, a leading global dental products supplier, announced the acquisition of Salvin Dental Specialties, a North Carolina-based company specializing in regenerative biomaterials, surgical instruments, and equipment for implant dentistry. The acquisition strengthens Young Innovations’ position as the largest implant-agnostic dental supplier in the industry. Salvin’s leadership team, including CEO William Simmons and President Greg Slayton, will continue to lead operations, while founder Bob Salvin will serve as an advisor. The move underscores Young Innovations’ commitment to expanding its presence in the oral surgery market and supporting the continued growth of Salvin’s brand, team, and customer base
- In October 2024, Haleon, a global leader in consumer health, announced a £130 million investment in a new Global Oral Health Innovation Centre in Weybridge, Surrey. Set to open in 2027, the 90,000 sq. ft. facility will house 450 employees and feature digitally enabled research labs, consumer behavior research spaces, and sustainable design targeting a ‘BREEAM Outstanding’ rating. The initiative reflects Haleon’s commitment to continuous innovation in its oral health brands such as Sensodyne, Polident/Poligrip, Aquafresh, and Corsodyl, while reinforcing the UK’s role as a global hub for life sciences and R&D
